The CEFOXITIN FOR INJECTION is a the manufacturer industrial component. Key specifications include physical_form: POWDER, administration: INTRAMUSCULAR OR INTRAVENOUS, primary_container_type: VIAL, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 25, primary_container_content_quantity: 2.000 GRAMS OF ACTIVE INGREDIENT G. This part is cataloged in the Federal Logistics Information System (FLIS) under NSN 6505-01-104-6393, indicating validated use in U.S.
government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels. Verify compatibility with your specific system configuration before ordering.
| physical_form | POWDER |
| administration | INTRAMUSCULAR OR INTRAVENOUS |
| primary_container_type | VIAL |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 25 |
| primary_container_content_quantity | 2.000 GRAMS OF ACTIVE INGREDIENT G |
| active_medicament_medicinal_strength | 2.000 GRAMS CEFOXITIN EQUIVALENT G |
| part_name_assigned_by_controlling_agency | CEFOXITIN SODIUM STERILE USP 2GM VIAL 25S |
| NSN | 6505-01-104-6393 |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | CEFOXITIN SODIUM STERILE USP 2GM VIAL 25S |
| PRIMARY CONTAINER TYPE | VIAL |
| SPECIAL FEATURES | 20 ML. SIZE VIAL. AFTER INITIAL CONSTITUTION, THE SOLUTION MAINTAINS SATISFACTORY POTENCY FOR 6 HOURS AT ROOM TEMPERATURE OR FOR 1 WEEK UNDER REFRIGERATION (BELOW 5 C (41 F)). STORE DRY MATERIAL BETWEEN 2 TO 25 C (36 TO 77 F). AVOID EXPOSURE TO TEMPERATURES ABOVE 50 C (122 F). |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| TOTAL PRIMARY CONTAINER QUANTITY | 25 |
| ADMINISTRATION | INTRAMUSCULAR OR INTRAVENOUS |
| PRIMARY CONTAINER CONTENT QUANTITY | 2.000 GRAMS OF ACTIVE INGREDIENT G |
| PHYSICAL FORM | POWDER |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 2.000 GRAMS CEFOXITIN EQUIVALENT G |